NCT04112147 - A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 10, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions

Chronic Hepatitis B

Interventions

DRUG

Antroquinonol capsule 100mg

Patients will receive 12-week of 50mg BID Antroquinonol

DRUG

Antroquinonol capsule 200mg

Patients will receive 12-week of 100mg BID Antroquinonol

DRUG

Placebo oral capsule

Patients will receive 12-week of 100mg BID Antroquinonol placebo

Trial Locations (1)

RECRUITING

Chung Shan Medical University hospital, Taichung